HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure ProphylaxisVerena Muzio, Sheikh MF Akbar, Isabel Parejo González et al.|Euroasian Journal of Hepato-Gastroenterology|2021Cited by 12
A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trialIdelsis Esquivel-Moynelo, Iraldo Bello Rivero, Jesus Perez-Escribano et al.|Annals of Antivirals and Antiretrovirals|2021Cited by 2